ARTICLE | Distillery Therapeutics
Zelboraf-based PROTAC for melanoma, lung cancer expressing BRAF mutations
February 26, 2021 10:04 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; lung cancer...
BCIQ Company Profiles
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; lung cancer...
BCIQ Company Profiles
BCIQ Company Profiles